Synthesis, antimycobacterial activity evaluation, and QSAR studies of chalcone derivatives

https://doi.org/10.1016/j.bmcl.2006.12.112Get rights and content

Abstract

In order to develop relatively small molecules as antimycobacterial agents, twenty-five chalcones were synthesized, their activity was evaluated, and quantitative structure–activity relationship (QSAR) was developed. The synthesis was based on the Claisen-Schimdt scheme and the resultant compounds were tested for antitubercular activity by luciferase reporter phage (LRP) assay. Compound C24 was found to be the most active (∼99%) in this series based on the percentage reduction in Relative Light Units at both 50 and 100 μg/ml levels, followed by compound C21. Four compounds at the 50 μg/ml and eight compounds at the 100 μg/ml showed activity above 90% level. QSAR model was developed between activity and spatial, topological, and ADME descriptors for the 50 μg/ml data. The statistical measures such as r, r2, q2, and F values obtained for the training set were in acceptable range and hence this relationship was used for the test set. The predictive ability of the model is satisfactory (q2 = 0.56) and it can be used for designing similar group of compounds.

Graphical abstract

Twenty-five chalcones were synthesized, and their activity was evaluated by luciferase reporter phage (LRP) assay, and quantitative structure–activity relationship (QSAR) was developed.

  1. Download : Download full-size image

Section snippets

Acknowledgment

Authors thank Dr. Moni (SAIF, IIT) for providing spectral analysis.

References and notes (28)

  • M. Liu et al.

    Bioorg. Med. Chem.

    (2003)
  • J. Patole et al.

    Bioorg. Med. Chem. Lett.

    (2006)
  • M. Karelson

    Molecular Descriptors in QSAR/QSPR

    (2000)
  • P.M. Sivakumar et al.

    Chem. Pharm. Bull.

    (2007)
  • J. Matyk et al.

    IL Farmaco.

    (2005)
  • H.M. Blumberg et al.

    J. Am. Med. Assoc.

    (2005)
  • C.D. Deangelis et al.

    J. Am. Med. Assoc.

    (2005)
  • C. Dye et al.

    J. Am. Med. Assoc.

    (2005)
  • World Health Organization. Global tuberculosis. 2002 Doc. WHO/CDS/TB/2000,...
  • (a)Sensi, P.; Grassi, G. In Burger’s Medicinal Chemistry and Drug Discovery; 5th ed.; John Wiley & Sons. Inc., 1996;...C.B. Inderlied et al.

    Clin. Microb. Rev.

    (1993)
    (c)Mandell, G. L.; Petri, W. A., Jr. In Goodman and Gilman’s The Pharmacological Basis of Therapeutics; 9th ed.; McGraw...
  • S.E. Hoffner et al.

    Eur. J. Clin. Infect. Dis

    (1988)
    K. Mikusova et al.

    Antimicrob. Agents Chemother.

    (1995)
    A. Telenti et al.

    Nat. Med.

    (1997)
    S. Sreevatsan et al.

    Antimicrob. Agents. Chemother.

    (1997)
  • L. Ballell et al.

    Antimicrob. Agents. Chemother.

    (2005)
  • S. Kanokmedhakul et al.

    Planta Med.

    (2002)
  • Y.M. Lin et al.

    Bioorg. Med. Chem.

    (2002)
  • Cited by (0)

    View full text